BIIB
Biogen Inc
Price:  
214.41 
USD
Volume:  
980,423.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen Relative Valuation

12.7%
Upside

As of 2024-05-30, the Relative Valuation of Biogen Inc (BIIB) is 241.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 214.41 USD, the upside of Biogen Inc based on Relative Valuation is 12.7%.

The range of the Relative Valuation is 211.68 - 328.19 USD.

Range Selected
Trailing P/E multiples 30.3x - 41.0x 33.6x
Forward P/E multiples 27.8x - 31.5x 28.1x
Fair Price 211.68 - 328.19 241.59
Upside -1.3% - 53.1% 12.7%
214.41 USD
Stock Price
241.59 USD
Fair Price

Biogen Relative Valuation - Historical P/E Data

Date P/E
2024-05-30 27.47
2024-05-29 26.76
2024-05-28 27.30
2024-05-24 27.18
2024-05-23 27.22
2024-05-22 28.11
2024-05-21 28.42
2024-05-20 28.90
2024-05-17 28.78
2024-05-16 28.71
2024-05-15 29.37
2024-05-14 28.32
2024-05-13 28.12
2024-05-10 27.64
2024-05-09 27.80
2024-05-08 27.42
2024-05-07 27.32
2024-05-06 27.63
2024-05-03 27.15
2024-05-02 26.65
2024-05-01 26.97
2024-04-30 26.81
2024-04-29 26.90
2024-04-26 26.07
2024-04-25 25.27
2024-04-24 25.21
2024-04-23 24.11
2024-04-22 24.23
2024-04-19 24.26
2024-04-18 23.78
2024-04-17 23.98
2024-04-16 24.36
2024-04-15 24.56
2024-04-12 24.73
2024-04-11 25.42
2024-04-10 25.15
2024-04-09 25.78
2024-04-08 25.58
2024-04-05 25.44
2024-04-04 25.62
2024-04-03 25.76
2024-04-02 25.91
2024-04-01 26.81
2024-03-28 26.91
2024-03-27 27.00
2024-03-26 26.46
2024-03-25 27.04
2024-03-22 27.22
2024-03-21 27.55
2024-03-20 27.23